Comparing Antibiotics and Placebo for Ear Infections in Toddlers
Official title: Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Otitis Media)
Run by University of Pittsburgh · NCT07730814 · Data updated 2026-11-12
This trial tests whether amoxicillin, amoxicillin-clavulanate, or a placebo help reduce symptoms in children with acute otitis media.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 6 Months to 36 Months |
| Sex | All |
| Enrollment | 1100 (estimated) |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 5 sites (Denver, Colorado and 4 other locations) |
| Status | Recruiting |
| Started | October 1, 2026 |
| Main results expected | December 18, 2031 |
| Study ends | March 17, 2032 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07730814 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 6 months to under 36 months with a clinical diagnosis of acute otitis media.
✕Probably not a fit
Children for whom antibiotics do not reduce symptoms or who receive a placebo may not experience a benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, randomized, double-blind study in which children aged 6 to less than 36 months with acute otitis media receive either amoxicillin, amoxicillin-clavulanate, or a matching placebo. Families and investigators are unaware of the assignment to prevent bias, and daily caregiver-reported symptom diaries track symptom severity. The primary goal is to compare average daily symptom burden across the three treatment groups, adjusting for initial illness severity and fever/age factors. Results aim to inform antimicrobial prescribing decisions for pediatric ear infections and support more targeted use of antibiotics. Secondary analyses will explore whether baseline symptoms, fever, age, or antibiotic response influence outcomes.
Why it matters
Potential benefit: If successful, the study could clarify when antibiotics help children with ear infections and guide more effective, appropriate treatment choices.
How similar studies have gone: Prior research in antibiotic use for AOM has yielded mixed results; this trial adds rigorous, blinded comparison to assess relative benefits.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Age 6 months to \<36 months. * Clinical diagnosis of AOM. Exclusion Criteria * Known allergy or other contraindication to oral amoxicillin or clavulanate * Prior use of systemic antibiotics in the last 7 days * History of renal impairment * History of hepatic impairment * Phenylketonuria or allergy to aspartame * History of craniofacial abnormalities * Concurrent bacterial infection requiring systemic antibiotic therapy (e.g., pneumonia, streptococcal pharyngitis) * Ill appearance, systemic toxicity, or immunodeficiency * Incomplete pneumococcal vaccination, defined as receipt of fewer than three doses of a pneumococcal conjugate vaccine * Parent or caregiver unable to complete study surveys in English or Spanish * Previous randomization into either MEASURE trial within the last 6 months * Mastoiditis * Conjunctivitis * Temperature ≥39°C and AOM-SOS score ≥35 * Cochlear implants * Spontaneous tympanic membrane perforation with otorrhea at presentation (participants who develop perforation and otorrhea after consent remain eligible)
Where it's running
-
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States Recruiting -
University of Colorado, Denver
Denver, Colorado, United States Not yet recruiting -
Duke University Hospital
Durham, North Carolina, United States Not yet recruiting -
Cincinnati Children's Hospital
Cincinnati, Ohio, United States Not yet recruiting -
Seattle Children's Hospital
Seattle, Washington, United States Not yet recruiting
Study contacts
- Principal investigator: Nader Shaikh, MD — University of Pittsburgh
- Study coordinator: Jane Luce, MPH
- Email: lucej2@upmc.edu
- Phone: 412-383-7853
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Home Medentum Diagnostik device for children with asthma and ear and throat problems
This project will try a multisensor Medentum Diagnostik device and app with AI to help diagnose asthma flare-ups, ear infections, and strep throat in children ages 3–17 by comparing telehealth-supported home use to usual in-person care.
-
Shortening antibiotic courses for common throat and chest infections in primary care with doctor–pharmacist teamwork and viral‑circulation updates
This project will test whether giving primary care doctors and pharmacists extra information about circulating viruses plus a shared protocol helps shorten antibiotic courses for patients with common respiratory infections.
-
wSp vaccine to prevent pneumococcal colonization in young children
This will test whether two doses of the wSp vaccine can safely reduce pneumococcal bacteria in the nose of healthy infants who have already received PCV20.
-
AI-guided eardrum photos to improve diagnosis of ear infections in infants
This will test an AI app that reads photos of infants' eardrums to see if it changes how doctors diagnose ear infections and prescribe antibiotics for children 6–24 months with cold symptoms.
-
Parent-led Digital Ear Imaging to Detect Acute Otitis Media
Parents use a digital otoscope at home and AI analyzes the images to see if a child has acute otitis media, aiming to reduce unnecessary doctor visits.
-
Reducing unnecessary antibiotic use for children with ear infections
This study is testing two different ways to help doctors give fewer unnecessary antibiotics to kids with ear infections to see which one makes parents happier and follows health guidelines better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.